C1q-bearing immune complexes induce IL-8 secretion in human umbilical vein endothelial cells (HUVEC) through protein tyrosine kinase- and mitogen-activated protein kinase-dependent mechanisms: Evidence that the 126 kD phagocytic C1q receptor mediates immune complex activation of HUVEC

Clinical and Experimental Immunology

Volumn 125, Issue 3, 2001, Pages 360-367

  Xiao, S ^a   Xu, C ^a   Jarvis, J N ^a  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

Antigen antibody complex; C1q; Endothelium; IL 8; MAP kinase

Indexed keywords

COMPLEMENT COMPONENT C1Q; CYCLOHEXIMIDE; GENISTEIN; IMMUNOGLOBULIN M; INTERLEUKIN 8; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MONOCLONAL ANTIBODY; PROTEIN TYROSINE KINASE; UO 126;

ARTICLE; CONTROLLED STUDY; CROSS LINKING; DOSE TIME EFFECT RELATION; ENDOTHELIUM CELL; ENZYME ACTIVATION; HUMAN; HUMAN CELL; INFLAMMATION; NORTHERN BLOTTING; PRIORITY JOURNAL; UMBILICAL VEIN;

ANTIGEN-ANTIBODY COMPLEX; ANTIGENS, CD44; BUTADIENES; CARRIER PROTEINS; COMPLEMENT C1Q; COMPLEMENT PATHWAY, CLASSICAL; ENDOTHELIUM, VASCULAR; GENISTEIN; HUMANS; INTERLEUKIN-8; MEMBRANE GLYCOPROTEINS; MITOCHONDRIAL PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASES; NITRILES; PHAGOCYTOSIS; PROTEIN-TYROSINE KINASES; RECEPTORS, COMPLEMENT; SIGNAL TRANSDUCTION; UMBILICAL VEINS;

EID: 0035714508     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2001.01597.x     Document Type: Article

References (49)

1. Platelets, endothelium, and vasospasm
2. Vascular endothelium in health and disease
3. Cytokines and endothelial cell biology
4. 19S IgM rheumatoid factor-7S IgG rheumatoid factor immune complexes isolated in patients with rheumatoid arthritis
5. Circulating immune complexes in rheumatoid arthritis. A prospective study using five immunoassays
6. Composition and biological behaviour of immune complexes isolated from synovial fluid of patients with juvenile rheumatoid arthritis (JRA)
7. Complement activation and immune complexes in children with polyarticular juvenile rheumatoid arthritis: A longitudinal study
8. Study of circulating immune complex size in systemic lupus erythematosus
9. Physiological and pathological aspects of circulating immune complexes
10. C5a-induced expression of P-selectin in endothelial cells
11. Complement protein C5b-9 induces secretion of high molecular weight multimers of endothelial von Willebrand factor and translocation of granule membrane protein GMP-140 to the cell surface
12. The complement subcomponent C1q mediates binding of immune complexes and aggregates to endothelial cells in vitro
13. Isolation, cDNA cloning, overexpression of a 33 kD cell surface glycoprotein that that binds the globular 'heads' of C1q
14. Intracellular localization of the human receptor for the globular domains of C1q
15. Complement component C1 and the collectins: Parallels between routes of acquired of acquired and innate immunity
16. C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes. Complement deficiency and systemic lupus erythematosus reconsidered
17. Cell-surface protein identified on phagocytic cells modulates the C1q-mediated enhancement of phagocytosis
18. C1qRp, the C1q receptor that enhances phagocytosis, is detected specifically in human cells of myeloid lineage endothelial cells, and platelets
19. Identification of C1q as the heat-labile serum cofactor required for immune complexes to stimulate endothelial expression of adhesion molecules E-selectin and inter-cellular and vascular adhesion molecules 1
20. The first subcomponent of complement, C1q triggers the production of IL-8, IL-6 and monocyte chemoattractant peptide-1 by human umbilical vein endothelial cells
21. Culture of human endothelial cells derived from umbilical veins
22. Immune complex size and complement regulate cytokine production by peripheral blood mononuclear cells
23. Complement deposition on immune complexes reduces the frequencies of metabolic, proteolytic, and superoxide oscillations of migrating neutrophils
24. C3-containing serum immune complexes in patients with systemic lupus erythematosus: Correlation to disease activity and comparison with other rheumatic diseases
25. Interleukin 4 or oncostatin M induces a prolonged increase in p-selectin mRNA and protein in human endothelial cells
26. In vitro induction of proinflammatory cytokine secretion by juvenile rheumatoid arthritis synovial fluid immune complexes
27. Human choriocarcinoma JAR cells constitutively express pro-interleukin-1β that can be released with Fcγ receptor engagement
28. Pathogenesis, mechanisms of inflammation in childhood rheumatic diseases
29. Differences among immune complexes: Association of C1q in SLE immune complexes with renal disease
30. IgG and IgA antibodies to the collagen-like region of C1q in rheumatoid vasculitis
31. Detection of Fcg receptors on human endothelial cells stimulated with cytokines tumor necrosis factor alpha (TNFα) and interferon-gamma (IFN-γ)
32. Dermal microvascular endothelial cells express CD32 receptors in vivo and in vitro
33. Phagocytic molecules that bind the collagen-like region of C1q. Involvement in the C1q-mediated enhancement of phagocytosis
34. Immune complex mediated downregulation of cholesterol 27-hydroxylase in human arterial endothelial cells (HAEC) and THP-1 monocytoid cells is mediated by the 126 kD C1q receptor
35. 3 integrins (GP11b/111a) and the expression of P-selectin and procoagulant activity
36. DNA levels in circulating immune complexes decrease at severe SLE flares - Correlation with complement component C1q
37. AntiC1q affinity isolated circulating immune complexes correlate with extra-articular rheumatoid disease
38. Primate erythrocyte-immune complex-clearing mechanism
39. The role of complement and its receptors in the elimination of immune complexes
40. cDNA cloning and primary structure analysis of C1qRp, the human C1q/MBL/SPA receptor that mediates enhances phagocytosis in vitro
41. Genistein, a dietary-derived inhibitor of in vitro angiogenesis
42. Involvement of mitogen-activated protein kinase pathways in interleukin-8 production by human monocytes and polymorphonuclear cells stimulated with lipopolysaccharide or mycoplasma fermentans membrane lipoproteins
43. Molecular mechanism of interleukin-8 gene expression
44. Distinct mechanisms for regulation of the IL- 8 gene involve synergism and cooperativity between C/EBP and Fκ
45. Production of IL-8 and monocyte chemotactic peptide-1 by peripheral blood monocytes. Disparate responses to phytohemag-glutinin and lipopolysaccharide
46. Interferon-γ upregulates interleukin-8 gene expression in human monocytic cells by a posttranscriptional mechanism
47. Role of cytokines in rheumatoid arthritis
48. Expression of the cytokine RANTES in human rheumatoid synovial fibroblasts. Differential regulation of RANTES and interleukin-8 genes by inflammatory cytokines
49. Differential action of cycloheximide and activation stimuli on transcription of tumor necrosis factor-α, IL-1β, IL-8, and P53 genes in human monocytes